Axiom Investors LLC Haemonetics Corp Transaction History

Axiom Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $975,885 - $1.21 Million	-12,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $1.54 Million - $2.16 Million	-18,170 Reduced 58.48%	12,900 $1.16 Million
Q1 2020 May 14, 2020	SELL	$74.34 - $121.82 $1.11 Million - $1.82 Million	-14,980 Reduced 32.53%	31,070 $3.1 Million
Q4 2019 Feb 13, 2020	SELL	$114.37 - $129.46 $369,872 - $418,673	-3,234 Reduced 6.56%	46,050 $5.29 Million
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $118,448 - $140,043	-1,011 Reduced 2.01%	49,284 $6.22 Million
Q2 2019 Aug 07, 2019	BUY	$81.74 - $120.34 $2.25 Million - $3.31 Million	27,543 Added 121.06%	50,295 $6.05 Million
Q1 2019 May 13, 2019	SELL	$83.25 - $102.12 $1.77 Million - $2.18 Million	-21,317 Reduced 48.37%	22,752 $1.99 Million
Q4 2018 Feb 14, 2019	BUY	$90.66 - $116.63 $4 Million - $5.14 Million	44,069 New	44,069 $4.41 Million

337

55.2M

383K

45.1K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.1B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.